Delivery Order SPE2DB22D1202-SPE2DB25FVCM4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,839.36 for Ivermectin 1% Cream (45GM) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ivermectin 1% Cream in 45-gram units. This firm fixed-price delivery order, valued at $2,240.06, represents a non-competitive, non-set-aside procurement with an ultimate completion date of August 8, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ivermectin 1% cream, 45 gm. The contract is a firm fixed-price delivery order with a ceiling value of $2,040.05 and an ultimate completion date of August 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp, a for-profit organization, is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a...
- This is a $1,120.06 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ivermectin 1% cream, 45 gm, with a period of performance through June 11, 2025. The contract is not set-aside and was awarded on a competitive basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,225.07 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ivermectin 1% cream (45 gm). This delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.56 Firm Fixed Price Delivery Order is for the supply of 4566602576 Ivermectin 1% Cream, 45GM. The award has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is a delivery order with a firm fixed price of $1,032.42 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% Cream, 45 grams, with a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% Cream 45GM, with a ceiling value of $5,153.25 and a completion date of May 13, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ivermectin tablets, with a contract ceiling value of $2,185.96 and a completion deadline of August 22, 2025. The award, issued on August 21, 2025, represents a firm fixed-price delivery order utilizing no set-aside provisions, indicating the contract was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $282 delivery order to Amerisourcebergen Drug Corporation for Ivermectin 1% cream under its Prime Vendor program. As the prime contractor, Amerisourcebergen will supply 45-gram tubes of the topical medication to DLA from its facility in Conshohocken, Pennsylvania. The firm fixed price order is for delivery between July 10-11, 2023. DLA manages the Department of Defense's global supply chain and relies on contractors like Amerisourcebergen to provide...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVCM4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $6,150.80, for the supply of Ivermectin 1% Cream in 45-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation, issued on June 17, 2025, and scheduled for completion by June 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Defense Health Agency and broader military healthcare systems. This award is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement extending through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to meet competitive federal medical procurement requirements across multiple therapeutic domains, supporting military healthcare programs and federal veteran services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 6/17/25 |